Evidence map›Paper›PMID 33539918›Full record

ArticleThe Journal of biological chemistry

KCC2 is required for the survival of mature neurons but not for their development.

Georgina Kontou, Shu Fun Josephine Ng, Ross A Cardarelli, Jack H Howden, Catherine Choi, Qiu Ren, Miguel A Rodriguez Santos, Christopher E Bope, Jake S Dengler, Matt R Kelley and 5 more

Open access · goldAbstract read
In one paragraph

Article in The Journal of biological chemistry. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Allele specific expression in Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Neuronal KActa pharmacologica Sinica · 2024
    Review
  8. Article
  9. Article
  10. KFrontiers in cellular neuroscience · 2023
    Article
  11. Article
  12. Review
  13. Article
  14. Imbalance between the function of NaFrontiers in molecular neuroscience · 2022
    Article
  15. Article
  16. Role of GABAFrontiers in cellular neuroscience · 2022
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 3 countries.

Georgina KontouAstraZeneca-Tufts Laboratory of Basic and Translational Neuroscience, Tufts University School of Medicine, Boston, Massachusetts, USA; Department of Neuroscience, Tufts University School of Medicine, Boston, Massachusetts, USA.
Shu Fun Josephine NgAstraZeneca-Tufts Laboratory of Basic and Translational Neuroscience, Tufts University School of Medicine, Boston, Massachusetts, USA; Department of Neuroscience, Tufts University School of Medicine, Boston, Massachusetts, USA.
Ross A CardarelliAstraZeneca-Tufts Laboratory of Basic and Translational Neuroscience, Tufts University School of Medicine, Boston, Massachusetts, USA; Department of Neuroscience, Tufts University School of Medicine, Boston, Massachusetts, USA.
Jack H HowdenDepartment of Neuroscience, Physiology, and Pharmacology, University College London, London, UK.
Catherine ChoiDepartment of Neuroscience, Tufts University School of Medicine, Boston, Massachusetts, USA.
Qiu RenDepartment of Neuroscience, Tufts University School of Medicine, Boston, Massachusetts, USA.
Miguel A Rodriguez SantosDepartment of Neuroscience, Tufts University School of Medicine, Boston, Massachusetts, USA.
Christopher E BopeDepartment of Neuroscience, Tufts University School of Medicine, Boston, Massachusetts, USA.
Jake S DenglerDepartment of Neuroscience, Tufts University School of Medicine, Boston, Massachusetts, USA.
Matt R KelleyDepartment of Neuroscience, Tufts University School of Medicine, Boston, Massachusetts, USA.
Paul A DaviesDepartment of Neuroscience, Tufts University School of Medicine, Boston, Massachusetts, USA.
Josef T KittlerDepartment of Neuroscience, Physiology, and Pharmacology, University College London, London, UK.
Nicholas J BrandonAstraZeneca-Tufts Laboratory of Basic and Translational Neuroscience, Tufts University School of Medicine, Boston, Massachusetts, USA; Neuroscience, IMED Biotech Unit, AstraZeneca, Boston, Massachusetts, USA.
Stephen J MossAstraZeneca-Tufts Laboratory of Basic and Translational Neuroscience, Tufts University School of Medicine, Boston, Massachusetts, USA; Department of Neuroscience, Tufts University School of Medicine, Boston, Massachusetts, USA; Department of Neuroscience, Physiology, and Pharmacology, University College London, London, UK. Electronic address: Stephen.Moss@Tufts.edu.
Joshua L SmalleyDepartment of Neuroscience, Tufts University School of Medicine, Boston, Massachusetts, USA.
Tufts University · USUniversity College London · GB

Funding

Mechanisms that determine Glutamine synthetase activity in the brainR01NS081986 · NINDS · TUFTS UNIVERSITY BOSTON · PI MOSS, STEPHEN J · 2012 to 2022
$3.7M
Constructing inhibitory synapsesR01NS051195 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI MOSS, STEPHEN J · 2006 to 2014
$3.2M
Novel actions of neurosteroids on GABA (A) receptor traffickingR01MH097446 · NIMH · TUFTS UNIVERSITY BOSTON · PI DAVIES, PAUL ANDREW, MOSS, STEPHEN J · 2013 to 2017
$2.1M
Novel actions of neurosteroids on GABA (A) receptor traffickingR01NS108378 · NINDS · TUFTS UNIVERSITY BOSTON · PI DAVIES, PAUL ANDREW, MOSS, STEPHEN J · 2018 to 2022
$2.0M
Deficits in KCC2 activity and the pathophysiology of Status EpilepticusR01NS087662 · NINDS · TUFTS UNIVERSITY BOSTON · PI MOSS, STEPHEN J · 2014 to 2018
$2.0M
The role of ubiquitination in regulating GABA(A) receptor functional expressionR01NS056359 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI MOSS, STEPHEN J · 2007 to 2010
$1.4M
Determining the effects of human KCC2 mutations on neuronal excitabilityR21NS111338 · NINDS · TUFTS UNIVERSITY BOSTON · PI DAVIES, PAUL ANDREW · 2019 to 2020
$454k
Impaired KCC2 function underlies pharmacoresistant seizuresR21NS080064 · NINDS · TUFTS UNIVERSITY BOSTON · PI MOSS, STEPHEN J · 2013 to 2014
$452k
Sensory Hypersensitivity in Fragile X Syndrome Due to Deficits in Tonic Inhibition Reversed by Neuroactive SteroidsR21NS111064 · NINDS · TUFTS UNIVERSITY BOSTON · PI DAVIES, PAUL ANDREW · 2020 to 2021
$450k
NIMH NIH HHS R01 MH097446NINDS NIH HHS R01 NS051195NINDS NIH HHS R01 NS056359NINDS NIH HHS R01 NS081986NINDS NIH HHS R01 NS087662NINDS NIH HHS R01 NS108378NINDS NIH HHS R21 NS080064NINDS NIH HHS R21 NS111064NINDS NIH HHS R21 NS111338
6 · The paper itself

Abstract

The K

Indexed as

AnimalsApoptosisChloridesFemalegamma-Aminobutyric AcidK Cl- CotransportersMaleMiceMice, Inbred C57BLMice, KnockoutNeurogenesisNeuronsPotassiumPrimary Cell CultureReceptors, GABASeizuresChloridesgamma-Aminobutyric AcidK Cl- CotransportersPotassiumReceptors, GABASymportersapoptosiscell deathextrinsic pathwayKCC2seizures

Identifiers

PMID33539918
PMCPMC7949141
OpenAlexW3126819379

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.